Ph1b Study of a HC-7366 w/ Locally adv Inoperable or met RCC
Phase I Clinical Trial
A Phase 1b Open-Label Safety Tolerability and Efficacy Study of a HC-7366 in Combination with Belzutifan (WeliregTM) in Patients with Locally Advanced or Metastatic Renal Cell Carcinoma (HC366-RCC2311 / MK-6482-030)
Participating Locations